M. Alcorn

1.0k total citations
23 papers, 678 citations indexed

About

M. Alcorn is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, M. Alcorn has authored 23 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in M. Alcorn's work include Hematopoietic Stem Cell Transplantation (13 papers), Virus-based gene therapy research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). M. Alcorn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Virus-based gene therapy research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). M. Alcorn collaborates with scholars based in United Kingdom, Canada and United States. M. Alcorn's co-authors include Tessa L. Holyoake, Alan K. Burnett, I M Franklin, Linda Richmond, Edward J. Fitzsimons, C. Pearson, Emily Farrell, G. A. McDonald, P Tansey and David J. Dunlop and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Virology.

In The Last Decade

M. Alcorn

22 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Alcorn United Kingdom 14 420 195 144 139 131 23 678
T Shibuya Japan 12 235 0.6× 89 0.5× 183 1.3× 116 0.8× 113 0.9× 30 568
N Ginzton United States 12 321 0.8× 74 0.4× 191 1.3× 79 0.6× 230 1.8× 15 707
JL Abkowitz United States 14 340 0.8× 84 0.4× 208 1.4× 146 1.1× 216 1.6× 22 776
Priscilla Yam United States 16 501 1.2× 179 0.9× 241 1.7× 138 1.0× 537 4.1× 26 1.3k
Mustafa Kondakci Germany 15 401 1.0× 183 0.9× 53 0.4× 93 0.7× 130 1.0× 39 613
T Grünberger Canada 14 418 1.0× 203 1.0× 330 2.3× 164 1.2× 258 2.0× 26 960
MJ Willemse Netherlands 13 490 1.2× 100 0.5× 68 0.5× 106 0.8× 90 0.7× 13 805
L Souza United States 9 284 0.7× 439 2.3× 149 1.0× 47 0.3× 128 1.0× 10 818
Francis Ayuk Germany 13 212 0.5× 143 0.7× 114 0.8× 80 0.6× 111 0.8× 27 470
Taichi Azuma Japan 15 164 0.4× 249 1.3× 304 2.1× 80 0.6× 232 1.8× 48 655

Countries citing papers authored by M. Alcorn

Since Specialization
Citations

This map shows the geographic impact of M. Alcorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Alcorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Alcorn more than expected).

Fields of papers citing papers by M. Alcorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Alcorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Alcorn. The network helps show where M. Alcorn may publish in the future.

Co-authorship network of co-authors of M. Alcorn

This figure shows the co-authorship network connecting the top 25 collaborators of M. Alcorn. A scholar is included among the top collaborators of M. Alcorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Alcorn. M. Alcorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doig, A. T., et al.. (2011). PBSC Collection on the Optia Cell Separator Platform: Dose Prediction Based on a Benchmark “CE2” Collection Efficiency is Significantly More Accurate Than “Collect Ratio”-Based Dose Prediction Using Peripheral CD34+ Count Alone. Therapeutic Apheresis and Dialysis. 15(4). 6. 1 indexed citations
2.
Alcorn, M., et al.. (2005). Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia. 19(3). 381–389. 27 indexed citations
3.
Richmond, Linda, M. Alcorn, C. Pearson, et al.. (2002). CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail. Cytotherapy. 4(5). 407–413. 2 indexed citations
4.
Alcorn, M., J. Leland Booth, K. Mark Coggeshall, & Jordan P. Metcalf. (2001). Adenovirus Type 7 Induces Interleukin-8 Production via Activation of Extracellular Regulated Kinase 1/2. Journal of Virology. 75(14). 6450–6459. 55 indexed citations
5.
Cook, Gordon, Ian M. Franklin, Andrew Clark, et al.. (2000). INTERLEUKIN-10 Production and monocyte maturity in g-csf-mobilized peripheral blood stem cell transplants correlate with graft-versus host disease. Experimental Hematology. 28(7). 82–82. 1 indexed citations
6.
7.
Alcorn, M., Tessa L. Holyoake, Linda Richmond, et al.. (1997). CD34+ Cells Can Be Selected Efficiently from Cryopreserved Peripheral Blood Progenitor Cells and Can Retain Their Proliferative Potential. Journal of Hematotherapy. 6(5). 501–510. 11 indexed citations
8.
Holyoake, Tessa L., M. Alcorn, Linda Richmond, et al.. (1997). CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplantation. 19(11). 1095–1101. 91 indexed citations
9.
Alcorn, M., Tessa L. Holyoake, Linda Richmond, et al.. (1996). CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity.. Journal of Clinical Oncology. 14(6). 1839–1847. 90 indexed citations
10.
Alcorn, M. & Tessa L. Holyoake. (1996). Ex vivo expansion of haemopoietic progenitor cells. Blood Reviews. 10(3). 167–176. 16 indexed citations
11.
Holyoake, Tessa L., M. Alcorn, & I M Franklin. (1996). The CD34 antigen: Potential clinical advantages of CD34 selection. Clinical Oncology. 8(4). 214–221. 6 indexed citations
12.
Houston, Doreen Μ., et al.. (1995). Injuries suffered by dogs from riding in the back of open pickup trucks: a retrospective review of seventy cases.. PubMed. 36(8). 510–2.
13.
Dunlop, David J., et al.. (1994). Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue. British Journal of Cancer. 70(5). 943–945. 19 indexed citations
14.
Holyoake, Tessa L. & M. Alcorn. (1994). CD34 + positive haemopoietic cells:Biology and clinical applications. Blood Reviews. 8(2). 113–124. 51 indexed citations
15.
Holyoake, Tessa L., M Freshney, Ian B. Pragnell, et al.. (1993). Contrasting effects of rh‐MIP‐1α and TGF‐β1on chronic myeloid leukemia progenitors in vitro. Stem Cells. 11(S3). 122–128. 16 indexed citations
16.
Pendry, K., M. Alcorn, & Alan K. Burnett. (1993). Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation. British Journal of Haematology. 83(1). 45–52. 18 indexed citations
17.
McIlroy, S. G., M. S. McNulty, Danny Bruce, et al.. (1992). Economic Effects of Clinical Chicken Anemia Agent Infection on Profitable Broiler Production. Avian Diseases. 36(3). 566–566. 51 indexed citations
18.
Goudie, R. B., et al.. (1990). A sensitive method of screening for dominant T cell clones by amplification of T cell gamma gene rearrangements with the polymerase chain reaction. The Journal of Pathology. 162(3). 191–196. 34 indexed citations
19.
Burnett, Alan K., Dipnarine Maharaj, P Tansey, et al.. (1984). TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSION. The Lancet. 324(8411). 1068–1070. 104 indexed citations
20.
Burnett, Alan K., P Tansey, M. Alcorn, et al.. (1983). Haematological reconstitution following high dose and supralethal chemo‐radiotherapy using stored, non‐cryopreserved autologous bone marrow. British Journal of Haematology. 54(2). 309–316. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Shibuya Breakdown of academic impact, for papers by N Ginzton Breakdown of academic impact, for papers by JL Abkowitz Breakdown of academic impact, for papers by Priscilla Yam Breakdown of academic impact, for papers by Mustafa Kondakci Breakdown of academic impact, for papers by T Grünberger Breakdown of academic impact, for papers by MJ Willemse Breakdown of academic impact, for papers by L Souza Breakdown of academic impact, for papers by Francis Ayuk Breakdown of academic impact, for papers by Taichi Azuma
Rankless by CCL
2026